Edith Brutcher

691 total citations
20 papers, 498 citations indexed

About

Edith Brutcher is a scholar working on Oncology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Edith Brutcher has authored 20 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 7 papers in Surgery and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Edith Brutcher's work include Pancreatic and Hepatic Oncology Research (7 papers), Cancer Genomics and Diagnostics (4 papers) and Genetic factors in colorectal cancer (4 papers). Edith Brutcher is often cited by papers focused on Pancreatic and Hepatic Oncology Research (7 papers), Cancer Genomics and Diagnostics (4 papers) and Genetic factors in colorectal cancer (4 papers). Edith Brutcher collaborates with scholars based in United States, Singapore and United Kingdom. Edith Brutcher's co-authors include Bassel F. El‐Rayes, Zhengjia Chen, Shishir K. Maithel, Natalyn Hawk, David A. Kooby, Jerome C. Landry, John Kauh, Sungjin Kim, Walid L. Shaib and Hemchandra Mahaseth and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Edith Brutcher

18 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edith Brutcher United States 12 373 158 130 122 108 20 498
María Jesús Rubio Spain 16 180 0.5× 344 2.2× 69 0.5× 44 0.4× 58 0.5× 48 693
J Genollá Spain 11 198 0.5× 89 0.6× 82 0.6× 134 1.1× 53 0.5× 37 447
Ryota Ishiwata Japan 6 436 1.2× 146 0.9× 178 1.4× 47 0.4× 104 1.0× 6 560
Jacob M. Estes United States 12 144 0.4× 202 1.3× 83 0.6× 57 0.5× 79 0.7× 36 516
Julien Volet France 10 262 0.7× 109 0.7× 119 0.9× 60 0.5× 95 0.9× 23 361
Jean Torrisi United States 7 122 0.3× 67 0.4× 91 0.7× 21 0.2× 29 0.3× 11 307
Robert Bachmann Germany 11 195 0.5× 169 1.1× 99 0.8× 14 0.1× 100 0.9× 36 424
Chukwuemeka Ihemelandu United States 16 255 0.7× 472 3.0× 109 0.8× 21 0.2× 184 1.7× 28 778
T. Giannakakis Greece 13 367 1.0× 68 0.4× 90 0.7× 60 0.5× 121 1.1× 24 457
Katrin Hefler‐Frischmuth Austria 11 204 0.5× 71 0.4× 118 0.9× 39 0.3× 59 0.5× 17 479

Countries citing papers authored by Edith Brutcher

Since Specialization
Citations

This map shows the geographic impact of Edith Brutcher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edith Brutcher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edith Brutcher more than expected).

Fields of papers citing papers by Edith Brutcher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edith Brutcher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edith Brutcher. The network helps show where Edith Brutcher may publish in the future.

Co-authorship network of co-authors of Edith Brutcher

This figure shows the co-authorship network connecting the top 25 collaborators of Edith Brutcher. A scholar is included among the top collaborators of Edith Brutcher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edith Brutcher. Edith Brutcher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Switchenko, Jeffrey M., et al.. (2023). The Impact of Poorly Differentiated Histology on Immunotherapy in Advanced Gastrointestinal Cancers. Oncology. 101(4). 213–223.
2.
Brutcher, Edith, et al.. (2022). Mismatch Repair–Deficient Metastatic Pancreatic Cancer. Pancreas. 51(8). e102–e103. 2 indexed citations
3.
Şahin, İbrahim Halil, Edith Brutcher, Katherine E. Smith, et al.. (2020). Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer Living With HIV: A Perspective on Recent Progress and Future Needs. JCO Oncology Practice. 16(6). 319–325. 14 indexed citations
4.
Mori, Megumi, Jocelyn Qi-Min Teo, Lisa Weiss, et al.. (2020). Nivolumab in Advanced Hepatocellular Carcinoma: Safety Profile and Select Treatment-Related Adverse Events From the CheckMate 040 Study. The Oncologist. 25(10). e1532–e1540. 16 indexed citations
5.
Morse, Michael A., Michael J. Overman, Edith Brutcher, et al.. (2019). Safety of Nivolumab plus Low-Dose Ipilimumab in Previously Treated Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer. The Oncologist. 24(11). 1453–1461. 77 indexed citations
6.
Brutcher, Edith. (2018). 5-Fluorouracil and Capecitabine: Assessment and Treatment of Uncommon Early-Onset Severe Toxicities Associated With Administration. Clinical journal of oncology nursing. 22(6). 627–634. 10 indexed citations
7.
Kim, Hyun S., Walid L. Shaib, Chao Zhang, et al.. (2018). Phase 1b study of pasireotide, everolimus, and selective internal radioembolization therapy for unresectable neuroendocrine tumors with hepatic metastases. Cancer. 124(9). 1992–2000. 23 indexed citations
8.
Brutcher, Edith, et al.. (2017). The Relationship Between Zinc and Quality of Life in Patients With Upper GI Cancer on Chemotherapy. Journal of the Advanced Practitioner in Oncology. 8(4). 338–345. 5 indexed citations
9.
Shaib, Walid L., Natalyn Hawk, Richard J. Cassidy, et al.. (2016). A Phase 1 Study of Stereotactic Body Radiation Therapy Dose Escalation for Borderline Resectable Pancreatic Cancer After Modified FOLFIRINOX (NCT01446458). International Journal of Radiation Oncology*Biology*Physics. 96(2). 296–303. 45 indexed citations
10.
Postlewait, Lauren M., Cecilia G. Ethun, David A. Kooby, et al.. (2016). A molecular biomarker targeted approach to adjuvant therapy for resected pancreatic adenocarcinoma: Results of a phase II prospective trial.. Journal of Clinical Oncology. 34(4_suppl). 230–230. 1 indexed citations
11.
Postlewait, Lauren M., Cecilia G. Ethun, David A. Kooby, et al.. (2016). Combination gemcitabine/cisplatin therapy and ERCC1 expression for resected pancreatic adenocarcinoma: Results of a Phase II prospective trial. Journal of Surgical Oncology. 114(3). 336–341. 11 indexed citations
12.
Shaib, Walid L., Sungjin Kim, Michael Goodman, et al.. (2015). Appendiceal Neuroendocrine, Goblet and Signet-Ring Cell Tumors: A Spectrum of Diseases with Different Patterns of Presentation and Outcome. Cancer Research and Treatment. 48(2). 596–604. 30 indexed citations
13.
Shaib, Walid L., Michael Goodman, Zhengjia Chen, et al.. (2015). Incidence and Survival of Appendiceal Mucinous Neoplasms. American Journal of Clinical Oncology. 40(6). 569–573. 44 indexed citations
14.
15.
Hawk, Natalyn, Sungjin Kim, Zhengjia Chen, et al.. (2014). Clinicopathologic Features and Outcome of Young Adults With Stage IV Colorectal Cancer. American Journal of Clinical Oncology. 38(6). 543–549. 21 indexed citations
16.
Mahaseth, Hemchandra, Edith Brutcher, John Kauh, et al.. (2013). Modified FOLFIRINOX Regimen With Improved Safety and Maintained Efficacy in Pancreatic Adenocarcinoma. Pancreas. 42(8). 1311–1315. 159 indexed citations
17.
Shaib, Walid L., Rahul Sharma, Edith Brutcher, et al.. (2013). Treatment utilization and surgical outcome of ampullary and duodenal adenocarcinoma. Journal of Surgical Oncology. 109(6). 556–560. 11 indexed citations
18.
Zafar, Syed F., Dattatraya Patil, John Kauh, et al.. (2013). Neuroendocrine tumors (NET) of the gastrointestinal tract: Patterns of management and experience at Winship Cancer Institute of Emory University.. Journal of Clinical Oncology. 31(4_suppl). 326–326. 1 indexed citations
19.
Mahaseth, Hemchandra, John Kauh, Edith Brutcher, et al.. (2012). Safety and efficacy of modified FOLFIRINOX in pancreatic cancer: A retrospective experience.. Journal of Clinical Oncology. 30(15_suppl). e14614–e14614. 7 indexed citations
20.
Zafar, Syed F., Dattatraya Patil, John Kauh, et al.. (2012). Neuroendocrine tumors (NET) of the gastrointestinal tract: Experience at Winship Cancer Institute of Emory University.. Journal of Clinical Oncology. 30(15_suppl). e14692–e14692.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by María Jesús Rubio Breakdown of academic impact, for papers by J Genollá Breakdown of academic impact, for papers by Ryota Ishiwata Breakdown of academic impact, for papers by Jacob M. Estes Breakdown of academic impact, for papers by Julien Volet Breakdown of academic impact, for papers by Jean Torrisi Breakdown of academic impact, for papers by Robert Bachmann Breakdown of academic impact, for papers by Chukwuemeka Ihemelandu Breakdown of academic impact, for papers by T. Giannakakis Breakdown of academic impact, for papers by Katrin Hefler‐Frischmuth
Rankless by CCL
2026